Views & Analysis | Perspectives on pharma industry issues

Skip to main content

Friday 12 December 2025

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Patients

pharmaphorum podcast Episode 228, Ruth Chambers, Raparu Consult CIC

The NHS, system burden, and a transformation prescription, w...

Dr Ruth Chambers OBE, co-director of Raparu Consult CIC and a visiting professor at Staffordshire University, discusses her book on the NHS.

Digital

AI screening of lungs in human body digital display

Garbage in, garbage out: The hidden data crisis in pharma

This hidden data crisis is the fundamental barrier to scaling AI in the life sciences sector.

Sales & Marketing

playing chess transform your engagement strategy

Sponsored

How AI-driven customer centricity can transform your engagem...

AI-driven customer centricity is built on a continuously learning system that interprets behaviour, identifies intent, and delivers content or support

R&D

immersive medical education

The case for engagement in medical training: Why interactive...

Trainees need to be maximally empowered to connect the dots before they enter hospitals or labs.

R&D

pharmaphorum podcast Episode 227, Punit Dhillon, Skye Bioscience

On CB1s as an alternative to GLP-1s, with Punit Dhillon

In a new pharmaphorum podcast, Punit Dhillon, CEO of Skye Bioscience, discusses CB1 inhibitor antibodies in the obesity space.

Digital

Recap: Frontiers Health 2025

Recap: Frontiers Health 2025

If you’ve ever wondered what makes Frontiers Health one of the most influential global health innovation events, this recap video is the perfect intro

Sales & Marketing

launch concept of three ticks and a rocket symbol

Unlocking pharma launch potential: Integrated data strategie...

Launch teams need real-time, integrated intelligence to navigate tighter markets, faster timelines, and rising expectations.

Digital

Globalising Digital Health: Insights from Frontiers Health 2025

Globalising Digital Health: Insights from Frontiers Health 2...

American Telemedicine Association CEO Ann Mond Johnson sat down with pharmaphorum after her Frontiers Health keynote.

Load more results

Sales & Marketing

Sales & Marketing

HCP and patient looking positive

Sponsored

Bridging science and strategy: Medical Affairs at the heart ...

In this sponsored podcast, Cheryl Lubbert and Carolyn Whiting of Reverba discuss a new approach to pharma marketing, omnichannel, and medical affairs.

Sales & Marketing

12 questions with Jim Sage

Sponsored

12 Questions with Jim Sage

Jim Sage is a seasoned global pharmaceutical executive with extensive marketing, commercial, and leadership experience across major therapeutic areas.

Digital

Digital

AI screening of lungs in human body digital display

Garbage in, garbage out: The hidden data crisis in pharma

This hidden data crisis is the fundamental barrier to scaling AI in the life sciences sector.

Digital

e-clinical trials concept

How integrated patient experience platforms are revolutionis...

AI-powered integrated platforms offer an elemental shift in the way that clinical trials are conducted.

Market Access

Market Access

Globe superimposed over Bangkok

Sustaining the mature product portfolio through strategic ou...

Globalisation and the growth of emerging markets has created new opportunities to expand the reach for the mature portfolio.

Market Access

Consolidating data strategy for global success: Insights from Frontiers Health 2025

Consolidating data strategy for global success: Insights fro...

At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.

Editor's Picks

UK and US agree zero tariffs on pharma – with price rises

FDA clears trial of 'vectorised' ALS antibody from VectorY

Tracy Beth Hoeg will be fifth CDER head this year

FDA takes steps to limit non-human primate testing

FDA could hike user fees for ex-US drug programmes

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

Medically accurate representation of a cancer cell

Radiopharmaceutical innovation: Giving cancer drugs second c...

Molecular recycling could transform the economics and innovation of oncology drug discovery.

Oncology

Tumour representation at cellular level

ESMO 2025 in review: A new era in oncology, from AI to next-...

ESMO 2025 reflected a field in the midst of rapid evolution – one that is increasingly defined by personalisation and data-driven decision-making.

Oncology

pharmaphorum podcast Episode 222, Lew Bender, Intensity Therapeutics

Delving into the physics of cancer, with Lew Bender

In a new podcast, Intensity Therapeutics' Lew Bender discusses intra-tumourally injected therapeutics - a novel approach to cancer cell death.

Patients

Patients

pharmaphorum podcast Episode 228, Ruth Chambers, Raparu Consult CIC

The NHS, system burden, and a transformation prescription, w...

Dr Ruth Chambers OBE, co-director of Raparu Consult CIC and a visiting professor at Staffordshire University, discusses her book on the NHS.

Patients

circle of community in wooden figures

How connection can create impact in healthcare: Patient advo...

At ESMO 2025 in Berlin, VML Health presented the inaugural Patient Advocacy Summit.

Patients

A female patient takes a pharmacy delivery directly

DTC pharma is America’s newest care pathway. TrumpRx has exp...

Today’s DTP platforms vary widely in standards, screening protocols, clinical follow-up, data use, and integration with a patient’s broader care team

R&D

R&D

immersive medical education

The case for engagement in medical training: Why interactive...

Trainees need to be maximally empowered to connect the dots before they enter hospitals or labs.

R&D

pharmaphorum podcast Episode 227, Punit Dhillon, Skye Bioscience

On CB1s as an alternative to GLP-1s, with Punit Dhillon

In a new pharmaphorum podcast, Punit Dhillon, CEO of Skye Bioscience, discusses CB1 inhibitor antibodies in the obesity space.

R&D

HCP and positive looking patient

Sponsored

Thermo Fisher Scientific on the value of an integrated appro...

In a new sponsored video, Thermo Fisher Scientific’s Alberto Fernández discusses the company's Accelerator Drug Development solution.

Editor's Picks

UK and US agree zero tariffs on pharma – with price rises

FDA clears trial of 'vectorised' ALS antibody from VectorY

Tracy Beth Hoeg will be fifth CDER head this year

FDA takes steps to limit non-human primate testing

FDA could hike user fees for ex-US drug programmes

News

Woman wears neuro headset for depression

FDA clears first at-home device for depression

Flow Neuroscience has secured FDA approval for FL-100, the first at-home brain stimulation device for major depressive disorder.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company